Sab Biotherapeutics, Inc. · NASDAQ:SABS

BVF PARTNERS L P/IL reported a 9.99% stake in Sab Biotherapeutics, Inc. (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 14, 2025

BVF PARTNERS L P/IL reported a 9.99% stake in Sab Biotherapeutics, Inc., 5,167,618 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).

Stake
9.99%
Shares
5,167,618
Intent
Passive
What changed
Stake changed
Filed together
10 holders

The filing in full

HolderStakeShares
BIOTECHNOLOGY VALUE FUND L P6.10%3,041,111
BVF I GP LLC6.10%3,041,111
BIOTECHNOLOGY VALUE FUND II LP4.20%2,075,714
BVF II GP LLC4.20%2,075,714
Biotechnology Value Trading Fund OS LP0.09%44,444
BVF Partners OS Ltd.0.09%44,444
BVF GP HOLDINGS LLC9.90%5,116,825
BVF PARTNERS L P/IL9.99%5,167,618
BVF INC/IL9.99%5,167,618
LAMPERT MARK N9.99%5,167,618

Source

View original at SEC

Related